| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 1,081,800 | 1,133,100 | 1,041,300 | 1,292,900 | | Cost of Revenue | 957,700 | 956,400 | 853,800 | 1,140,300 | | | Gross Profit | 124,100 | 176,700 | 187,500 | 152,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 81,300 | 81,700 | 95,000 | 90,900 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,800 | 95,000 | 92,500 | 61,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,800 | 7,200 | 4,700 | (13,700) | | Earnings Before Interest And Taxes | 44,600 | 102,200 | 97,200 | 48,000 | | Interest Expense | 21,400 | 22,100 | 22,500 | 19,600 | | Income Before Tax | 23,200 | 80,100 | 74,700 | 28,400 | | Income Tax Expense | 3,900 | 24,500 | 25,000 | 10,400 | | Minority Interest | (7,100) |
-
|
-
| (400) | | | | Net Income From Continuing Ops | 12,300 | 55,800 | 49,800 | 17,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,300 | 55,800 | 49,800 | 17,900 | | Preferred Stock And Other Adjustments | 4,100 | (2,900) | (1,500) |
-
| | | Net Income Applicable To Common Shares | $16,400 | $52,900 | $48,300 | $17,900 |
|
0.13% Nasdaq 
0.34%
Income Statement
